Podcast

Dr. Lutz discusses testicular cancer awareness

Author(s):

Urology Times staff

“While we have these young men in our offices, we need to try and engage them for all of the necessary screening opportunities that will improve the quality of their lives moving forward,” says Michael Lutz, MD, in this podcast episode.

In this episode, Urology Times® Assistant Managing Editor Ben Saylor spoke with Dr. Michael Lutz about how urologists can raise testicular cancer awareness among their patients. Lutz is a partner in the Michigan Institute of Urology and is president of the MIU Men’s Health Foundation.

Related Videos
Jason Hafron, MD, considers the future for AI in urology
Jason Hafron, MD, considers the future for AI in urology
A panel of 5 experts on bladder cancer
Key Takeaways on the Evolving NMIBC Treatment Landscape
A panel of 5 experts on bladder cancer
Promising Developments in NMIBC
A panel of 5 experts on bladder cancer
Patient Monitoring Strategies in BCG-Unresponsive NMIBC
A panel of 5 experts on bladder cancer
Selecting Optimal Treatment in BCG-Unresponsive NMIBC
A panel of 5 experts on bladder cancer
Adverse Effect Management and the Role of Immunotherapy in NMIBC
A panel of 5 experts on bladder cancer
Quality of Life and Progression Considerations in BCG-Unresponsive NMIBC
Dr. Hafron on IsoPSA with PI-RADS for prostate biopsy decision-making
Dr. Hafron on IsoPSA with PI-RADS for prostate biopsy decision-making
A panel of 5 experts on bladder cancer
Overview of the QUILT Trial in BCG-Unresponsive NMIBC
A panel of 5 experts on bladder cancer
Efficacy and Safety Data from SunRISe-1
Related Content
blur image background of corridor in hospital or clinic image | Image Credit: @ whyframeshot - stock.adobe.com
April 18th 2025

U.S. News & World Report Names Michigan Institute of Urology’s Town Center ASC Among 2025 Best Ambulatory Surgery Centers

Michigan Institute of Urology
Ambulatory surgery centers were evaluated based entirely on objective, risk-adjusted measures of their patients’ outcomes.
Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD
May 17th 2025

Pearls & Perspectives: From Guidelines to Practice—Navigating the TRT Treatment Spectrum, with Alex Tatem, MD

Amy M. Pearlman, MD Alex Tatem, MD
Explore the latest insights on testosterone therapy, its benefits, and practical applications from leading urologists in men's health.
The potential role for IsoPSA in prostate cancer risk assessment
June 23rd 2024

The potential role for IsoPSA in prostate cancer risk assessment

Urology Times staff
"Looking at data, if you apply IsoPSA in a consistent manner, based on the studies published, you'll see up to a 55% reduction in unnecessary biopsies," says Jason M. Hafron, MD.
Pearls & Perspectives: Understanding and addressing priapism, with Serge Carrier, MD, and Gregory Broderick, MD
May 2nd 2025

Pearls & Perspectives: Understanding and addressing priapism, with Serge Carrier, MD, and Gregory Broderick, MD

Amy M. Pearlman, MD
Experts discuss urgent priapism management strategies, emphasizing timely intervention and collaboration for optimal patient outcomes.
Michigan Institute of Urology opens dedicated outpatient medical center for minimally invasive health care
December 13th 2023

Michigan Institute of Urology opens dedicated outpatient medical center for minimally invasive health care

Michigan Institute of Urology
The center will offer a comprehensive range of treatments, including prostate artery embolization for men suffering from benign prostatic hyperplasia with very large prostates.
Michigan Institute of Urology Opens New Sexual Wellness and Aesthetics Center for Men and Women called REDEEM
November 2nd 2023

Michigan Institute of Urology Opens New Sexual Wellness and Aesthetics Center for Men and Women called REDEEM

Michigan Institute of Urology
“Sexual wellness is critical to overall health and happiness. That’s why you see more men and women turning to specialty health clinics for solutions to problems they consider more aesthetic versus medical,” said Mitchell Hollander, MD.
© 2025 MJH Life Sciences

All rights reserved.